Cannabinoid research: ‘Pharma on the sidelines with binoculars, not with a blind eye’ 30-Jan-2019 By Ben Hargreaves The approval of the farm bill has intensified interest in CBD but Nexien BioPharma CEO warns pharma-grade products are needed for patients with serious conditions.